-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The aggregate amount of income or expense from ancillary business-related activities (that is to say, excluding major activities considered part of the normal operations of the business).
-
Summary
-
Allarity Therapeutics, Inc. quarterly/annual Nonoperating Income (Expense) history and growth rate from Q1 2023 to Q2 2024.
- Allarity Therapeutics, Inc. Nonoperating Income (Expense) for the quarter ending June 30, 2024 was $1.74M, a 1.91% decline year-over-year.
- Allarity Therapeutics, Inc. annual Nonoperating Income (Expense) for 2023 was $5.31M, a 68.5% decline from 2022.
- Allarity Therapeutics, Inc. annual Nonoperating Income (Expense) for 2022 was $16.9M, a 41080% increase from 2021.
Nonoperating Income (Expense), Quarterly (USD)
Nonoperating Income (Expense), YoY Quarterly Growth (%)